WASHINGTON, April 18, 2011 /PRNewswire-USNewswire/ -- The following statement was released today by the U.S. Agency for International Development:
"While we are disappointed in the news from the FEM-PreP study, funded by PEPFAR through USAID, other research on pre-exposure prophylaxis is underway. This is the nature of scientific research; some failures lead to other successes. We will continue to work with our colleagues in the scientific community to monitor the results of these and other research studies, in the hope that they will produce new tools for HIV/AIDS prevention."
For more information about the FEM-PrEP HIV Prevention Study and interim results, please visit: www.fhi.org/en/Research/Projects/FEM-PrEP.htm.
The U.S. President's Emergency Plan for AIDS Relief (PEPFAR) is the U.S. Government initiative to help save the lives of those suffering from HIV/AIDS around the world. This historic commitment is the largest by any nation to combat a single disease internationally, and PEPFAR investments also help alleviate suffering from other diseases across the global health spectrum. PEPFAR is driven by a shared responsibility among donor and partner nations and others to make smart investments to save lives. For more information, please visit www.PEPFAR.gov, http://twitter.com/uspepfar, or www.facebook.com/PEPFAR.
The American people, through the U.S. Agency for International Development (USAID), have provided economic and humanitarian assistance worldwide for nearly 50 years. For more information about USAID's programs, please visit: usaid.gov. To read our blog, see blog.usaid.gov.
Public Information: 202-712-4810
SOURCE U.S. Agency for International Development